Blue Cross Sued For Denying Gilead Hep C Drug Coverage
Blue Cross and Blue Shield of Florida Inc. wrongfully denied policyholders Gilead Sciences Inc.'s newly approved yet expensive treatment for hepatitis C, according to a putative class action filed Wednesday in...To view the full article, register now.
Already a subscriber? Click here to view full article